Nextage Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY
Period Ending	May '26 May 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	23	24	-	-	-	-
Enterprise Value	35	24	-	-	-	-
Last Close Price	0.68	0.79	0.34	0.58	2.21	3.09
PS Ratio	93.88	57.53	-	-	-	-
PB Ratio	1.12	-4.29	-	-	-	-
EV/Sales Ratio	143.75	57.99	-	-	-	-
Debt / Equity Ratio	0.62	-0.04	-0.14	-0.78	-	0.58
Net Debt / Equity Ratio	0.61	0.01	0.04	1.87	-	-0.85
Net Debt / EBITDA Ratio	-3.78	0.01	0.03	0.14	-	0.20
Net Debt / FCF Ratio	-5.36	0.05	0.05	0.13	-	0.19
Asset Turnover	0.01	0.57	0.67	-	-	-
Quick Ratio	0.06	0.05	0.24	0.75	-	1.67
Current Ratio	0.06	0.05	0.24	0.80	-	1.67
Return on Assets (ROA)	-8.38%	-296.88%	-191.17%	-	-	-
Return on Capital Employed (ROCE)	-13.30%	62.50%	151.50%	2248.10%	-	-249.30%
Earnings Yield	12.45%	-13.82%	-	-	-	-
FCF Yield	-	-3.35%	-	-	-	-
Buyback Yield / Dilution	57.55%	-12.68%	-4.79%	-6.98%	-127.75%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.